Supplier profile
Gilead Sciences s.r.o.
Every public-sector award we hold for this supplier, across Czechia and Luxembourg, from 29 Jan 2016 to 14 Aug 2026.
Awards won
157
all time
Attributed value
€9.3m + CZK 5.8bn
59 shared, unvalued
Buyers
29
public bodies
Active
2016–2026
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| Fakultní nemocnice Bulovka | 18 | CZK 899.8m |
| Fakultní nemocnice Brno | 16 | CZK 1.2bn |
| Fakultní nemocnice Olomouc | 13 | CZK 353.0m |
| Fakultní nemocnice Ostrava | 13 | CZK 643.0m |
| Fakultní nemocnice Plzeň | 12 | €464k + CZK 274.0m |
| Institut klinické a experimentální medicíny | 12 | €6.1m + CZK 745.3m |
| Fakultní nemocnice Hradec Králové | 9 | €2.8m + CZK 219.3m |
| Ústřední vojenská nemocnice - Vojenská fakultní nemocnice Praha | 9 | CZK 229.6m |
| Krajská zdravotní, a.s. | 8 | CZK 59.3m |
| Fakultní nemocnice u sv. Anny v Brně | 7 | CZK 2.8m |
What they win
Awards
Showing 126–150 of 157 awards we hold
- Czechia-Hradec Králové: Antivirals for systemic use ↗Fakultní nemocnice Hradec Královéshared awardawarded 18 Jan 2021
- Luxembourg-Luxembourg: Supply of Veklury (Remdesivir) for the Treatment of Covid-19 Patients Requiring Supplemental Oxygen ↗European Commission, Directorate-General for Health and Food Safety, Health Security and Vaccinationshared awardawarded 2 Dec 2020
- Czechia-Olomouc: Antineoplastic agents ↗Fakultní nemocnice Olomouc£66.4mawarded 20 Nov 2020
- Czechia-Prague: Antivirals for systemic use ↗Fakultní nemocnice v Motole£37.9mawarded 13 Nov 2020
- Czechia-Brno: Antivirals for systemic use ↗Fakultní nemocnice Brnoshared awardawarded 30 Oct 2020
- Czechia-Brno: Antivirals for systemic use ↗Fakultní nemocnice Brnoshared awardawarded 24 Jul 2020
- Czechia-Ostrava: Pharmaceutical products ↗Fakultní nemocnice Ostravashared awardawarded 7 Apr 2020
- Czechia-Prague: Antivirals for systemic use ↗Nemocnice Na Bulovce£165.3mawarded 28 Feb 2020
- Czechia-Ústí nad Labem: Antivirals for systemic use ↗Krajská zdravotní, a.s.£28.9mawarded 17 Feb 2020
- Czechia-České Budějovice: Medical preparations excluding dental consumables ↗Nemocnice České Budějovice, a.s.£10.1mawarded 13 Feb 2020
- Czechia-Brno: Antineoplastic agents ↗Fakultní nemocnice Brno£45.5mawarded 27 Dec 2019
- Czechia-Brno: Antivirals for systemic use ↗Fakultní nemocnice Brnoshared awardawarded 25 Oct 2019
- Czechia-Plzeň: Antivirals for systemic use ↗Fakultní nemocnice Plzeňshared awardawarded 4 Oct 2019
- Czechia-Brno: Antivirals for systemic use ↗Fakultní nemocnice Brnoshared awardawarded 23 Apr 2019
- Czech Republic-Brno: Antivirals for systemic use ↗Fakultní nemocnice Brnoshared awardawarded 11 Feb 2019
- Czech Republic-Ostrava: Pharmaceutical products ↗Fakultní nemocnice Ostravashared awardawarded 17 Jan 2019
- Czech Republic-Prague: Antivirals for systemic use ↗Institut klinické a experimentální medicíny£99.8mawarded 27 Nov 2018
- Czech Republic-Prague: Antivirals for systemic use ↗Institut klinické a experimentální medicíny£180.8mawarded 21 Nov 2018
- Czech Republic-Ostrava: Pharmaceutical products ↗Fakultní nemocnice Ostravashared awardawarded 20 Oct 2018
- Czech Republic-Plzeň: Antineoplastic and immunomodulating agents ↗Fakultní nemocnice Plzeňshared awardawarded 22 Sept 2018
- Czech Republic-Hradec Králové: Antineoplastic agents ↗Fakultní nemocnice Hradec Královéshared awardawarded 10 Aug 2018
- Czech Republic-Prague: Antivirals for systemic use ↗Institut klinické a experimentální mediciny£141.7mawarded 10 Aug 2018
- Czech Republic-Plzeň: Antivirals for systemic use ↗Fakultní nemocnice Plzeňshared awardawarded 3 Aug 2018
- Czech Republic-Hradec Králové: Antivirals for systemic use ↗Fakultní nemocnice Hradec Královéshared awardawarded 4 May 2018
- Czech Republic-Brno: Medicinal products for the blood and blood-forming organs ↗Fakultní nemocnice u sv. Anny v Brněshared awardawarded 3 Mar 2018
Possibly the same organisation
These entries differ from this one only by legal form or a bracketed qualifier, so they may be the same organisation — or a different registered company of the same name. They are kept apart on purpose: the figures on each page are per legal entity and are never combined.
- Gilead Sciences Ltd248 awards · £79.8m
- GILEAD SCIENCES, S.L.770 awards
- GILEAD SCIENCES, S.L.U.266 awards
- GILEAD SCIENCES S.R.L.183 awards
- GILEAD SCIENCES INC19 awards
- Gilead Sciences Pty Limited11 awards
- Gilead Sciences GmbH8 awards
- Gilead Sciences; SA6 awards
- Gilead Sciences SAS3 awards
- Gilead Sciences AB2 awards
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.